Related Experiment Video
Updated: Jun 24, 2025
08:44
Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
6.1K
Beyond the danger signal: RNA aggregates orchestrate immunotherapy
Quazi T H Shubhra1, Tivadar Feczkó2, Qiang Cai3
1Institute of Chemistry, University of Silesia in Katowice, Szkolna 9, 40-003 Katowice, Poland; Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Trends in Molecular Medicine
|June 12, 2024
Summary
RNA-lipid particle aggregates (RNA-LPAs) show promise in immunotherapy by reprogramming the tumor microenvironment to boost antitumor immunity. This approach targets primary tumors and generates systemic immunity, potentially leading to clinical benefits.
Area of Science:
- Immunotherapy
- Oncology
- Nanomedicine
Background:
- The tumor microenvironment (TME) often suppresses immune responses against cancer.
- Developing novel strategies to overcome immune suppression is crucial for effective cancer treatment.
Purpose of the Study:
- To investigate the potential of RNA-lipid particle aggregates (RNA-LPAs) as a novel immunotherapy platform.
- To evaluate the ability of RNA-LPAs to reprogram the TME and enhance antitumor immunity.
Main Methods:
- Utilized RNA-lipid particle aggregates (RNA-LPAs) for immunotherapy.
- Administered RNA-LPAs to target primary tumors and modulate the TME.
Main Results:
- Demonstrated that RNA-LPAs can reprogram the tumor microenvironment.
- Showcased the potentiation of antitumor immunity by RNA-LPAs.
- Observed the elicitation of robust systemic immunity following RNA-LPA treatment.
Conclusions:
- RNA-lipid particle aggregates (RNA-LPAs) represent a transformative approach in immunotherapy.
- This platform effectively targets primary tumors and induces systemic antitumor immunity.
- RNA-LPAs hold significant promise for translating preclinical findings into clinical applications.
Related Concept Videos
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
01:26Antigens Involved in Adaptive Immunity
485
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
485
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
01:28Cells of the Innate Immune Response
1.6K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K